[(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine

C12H15ClN4O — CID 105191750

IUPAC[(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine
SMILESCOc1cccc(C(NN)c2c(Cl)cnn2C)c1
InChIInChI=1S/C12H15ClN4O/c1-17-12(10(13)7-15-17)11(16-14)8-4-3-5-9(6-8)18-2/h3-7,11,16H,14H2,1-2H3
InChIKeyYRLALHCGPLAOHJ-UHFFFAOYSA-N
MW266.73 g/mol
LogP1.63
Rot. Bonds4

About [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine

[(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine (PubChem CID 105191750) has the molecular formula C12H15ClN4O and a molecular weight of 266.73 g/mol. Its IUPAC name is [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine.

Molecular Properties

Compound Name[(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine
PubChem CID105191750
Molecular FormulaC12H15ClN4O
Molecular Weight266.73 g/mol
Exact Mass266.09
IUPAC Name[(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine
SMILESCOc1cccc(C(NN)c2c(Cl)cnn2C)c1
InChIInChI=1S/C12H15ClN4O/c1-17-12(10(13)7-15-17)11(16-14)8-4-3-5-9(6-8)18-2/h3-7,11,16H,14H2,1-2H3
InChIKeyYRLALHCGPLAOHJ-UHFFFAOYSA-N
XLogP1.63
TPSA65.10 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500266.73
LogP ≤ 51.63
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(4-chloro-1-methylpyrazol-5-yl)-(3-propan-2-yloxyphenyl)methyl]hydrazine
CID 105338783
[(4-chloro-1-methylpyrazol-5-yl)-(3,5-dichlorophenyl)methyl]hydrazine
CID 105338868
[(3-ethoxyphenyl)-(4-methoxy-1-methylpyrazol-5-yl)methyl]hydrazine
CID 105192015
1-(4-chloro-1-methylpyrazol-5-yl)-1-(3,5-dimethoxyphenyl)-N-methylmethanamine
CID 105046678
[(4-chloro-1-methylpyrazol-5-yl)-pyridin-4-ylmethyl]hydrazine
CID 105196547
[(3-methoxyphenyl)-phenylmethyl]hydrazine
CID 105191567
[(4-chloro-1-methylpyrazol-5-yl)-(2-fluoro-6-methoxyphenyl)methyl]hydrazine
CID 105252513
[(4-bromo-1-propan-2-ylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine
CID 105191592
[(4-chloro-1-methylpyrazol-5-yl)-(2,3-dihydro-1H-inden-5-yl)methyl]hydrazine
CID 105338870
[(1-ethylpyrazol-4-yl)-(3-methoxyphenyl)methyl]hydrazine
CID 105191655
[(4-chloro-1-methylpyrazol-5-yl)-pyrimidin-2-ylmethyl]hydrazine
CID 105203738
[(3-ethyl-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine
CID 105283558

Frequently Asked Questions

What is the IUPAC name of [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine?
The IUPAC name of [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine (CID 105191750) is [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine.
What is the SMILES notation for [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine?
The canonical SMILES for [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine is COc1cccc(C(NN)c2c(Cl)cnn2C)c1.
What is the InChIKey of [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine?
The InChIKey is YRLALHCGPLAOHJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H15ClN4O/c1-17-12(10(13)7-15-17)11(16-14)8-4-3-5-9(6-8)18-2/h3-7,11,16H,14H2,1-2H3.
What are the key properties of [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine?
[(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine has a molecular weight of 266.73 g/mol, XLogP of 1.63, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(4-chloro-1-methylpyrazol-5-yl)-(3-methoxyphenyl)methyl]hydrazine is sourced from PubChem (CID 105191750), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).